Saras Capital

Generare is a biotechnology company specializing in the discovery of novel drug leads derived from soil bacteria. It has created a comprehensive map of the biosynthetic landscape, using experimental data to predict and access valuable new molecules with novel modes of action, thereby aiding pharmaceutical companies and research institutions in drug development.

Infinitopes is a cancer research organization focused on enhancing the immune system to prevent metastases and ultimately save lives. The company develops healthcare systems and therapeutic designs that integrate advanced tumor target identification technologies with efficient vector delivery systems. By applying this innovative platform in early-stage clinical trials, Infinitopes aims to improve patient outcomes in the fight against cancer and tumors, offering new hope for those affected by these diseases.

Parse Biosciences is a biotechnology company specializing in single-cell analysis and sequencing solutions. Founded in 2018 and based in Seattle, Washington, the company focuses on developing innovative technologies that simplify the sequencing process for researchers. By employing combinatorial cDNA barcoding directly within cells, Parse Biosciences eliminates the necessity for complex and costly microfluidic instruments. This technology allows for the fixing, freezing, and storage of samples, enabling researchers to conduct experiments with samples collected on different dates in a single run. This capability enhances sample handling and minimizes errors, ultimately improving the accuracy of results. The company aims to increase gene detection in individual cells while addressing common challenges associated with single-cell sequencing, thereby advancing research in various scientific fields.

Eden Bio is a biotechnology company focused on strain engineering to support fermentation businesses in their transition toward sustainable practices. Founded in 2021 and based in London, the company utilizes a proprietary machine-learning platform to identify non-intuitive genetic modifications that enhance the performance of microorganisms. By optimizing strains for factors such as yield and enzymatic activity, Eden Bio enables companies to improve protein production efficiently, ultimately saving them time and resources. Through its innovative approach, Eden Bio aims to facilitate advancements in the biotechnology sector, contributing to a more sustainable future in food production and fermentation.